Filing Details
- Accession Number:
- 0001127602-16-048952
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-06 17:29:21
- Reporting Period:
- 2016-04-05
- Filing Date:
- 2016-04-06
- Accepted Time:
- 2016-04-06 17:29:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1263805 | O Christian Henry | 5200 Illumina Way San Diego CA 92122 | Evp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-04-05 | 541 | $165.26 | 31,997 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-04-05 | 900 | $165.84 | 31,097 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-04-05 | 700 | $166.97 | 30,397 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 541 shares sold ranging from $164.66 to $165.60 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 900 shares sold ranging from $165.6725 to $166.4879 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 700 shares sold ranging from $166.80 to $167.1917 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.